JMP Securities Reiterates Market Outperform Rating on AN2 Therapeutics (ANTX) Feb 3, 2025 04:13AM
JMP Securities Reiterates Market Outperform Rating on AN2 Therapeutics (ANTX) Jan 28, 2025 05:42AM
JMP Securities Upgrades AN2 Therapeutics (ANTX) to Market Outperform Apr 2, 2024 03:37AM
AN2 Therapeutics to Present at JMP Securities Life Sciences Conference May 1, 2023 07:00AM